Novel Targeted Therapy for Metastatic Castration Resistant Prostate Cancer

Dr. Shore speaks about a new promising cancer treatment, known as antibody-cancer drug conjugates (ADCs). These advanced drugs work by specifically targeting and delivering a cancer-killing drug directly into prostate cancer cells, thus preventing damage to healthy cells and tissues. After this Dr. Shore discusses the TAMARACK clinical trial that is currently using this groundbreaking ADC Technology.